A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia

N/ANot Yet RecruitingNCT06745427

Region Stockholm100 enrolled

Overview

We will investigate the safety and efficiency of fertility-sapring treatment in ypung women witg endometrial cancer and endometrial intraepithelial hyperplasia

A multi-center prospective study on the oncological and reproductive outcomes and quality of life in young woman after fertility-sparing treatment of endometrial cancer and endometrial intraepithelial hyperplasia

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Endometrial Cancer Endometrial Intraepithelial Neoplasia Fertility-sparing Surgery

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Fertility sparing treatment of EC and EIN. * 18-45 Years old * From start study (Jan 2025 - end study Jan 2028) * All centras in Sweden Exclusion Criteria: * Not English och Swedish speaking

Outcomes

Primary Outcomes

Relaps of endometrial cancer or EIN after fertility-sparing treatment

Time frame: from enrollment to 2 years after fertility-sparing treatment

Secondary Outcomes

Live birth rate in women that has been treated with fertility-sparing treatment for EC or EIN

Time frame: From start of study to 2 years after fertility-sparing treatment

Central Contacts

Charlotta CR Riese, MD, PHD-student

CONTACT

+46703440206 charlotta.riese@ki.se

Kenny Rodriguez Wallberg, Proffessor

CONTACT

+46 73546 10 71 kenny.rodriguez-wallberg@ki.se

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.